Techniques

Bioavailability / Bioequivalence

Bioavailability and Bioequivalence studies play a key role during Drug Development, for new drug products as well as their generic equivalents. Post approval too, such studies will require to be conducted when changes are carried out in the manufacturing process.

Bioavailability studies are conducted for a new drug to establish essential pharmacokinetic parameters following a single or multiple dose administration. Two formulations of a drug are considered bioequivalent if there is no significant difference in the rate and extent of absorption when the active ingredient reaches the systemic circulation. In determining bioequivalence between two formulations, pharmacokinetic studies are conducted in a cross-over study in healthy volunteers.

With tremendous experience and capabilities, AnaCipher can offer following types of studies in healthy as well as patient population

  • Full replicate / Partial replicate reference scaled average bioequivalence studies
  • Truncated
BA/BE studies in healthy volunteers
Our expertise in conducting Bioavailability and Bioequivalence studies across wide array of dosage forms including

Solid Oral Formulations

(Tablets, Capsules, Soft Gels, and Sprinkles)

Topical Products

(Liquid orals, eg. Solutions & Suspensions)

Parenteral Formulations

(Injectables)

Inhalation Products

(Nasal and Oral Sprays)

Rectal and Vaginal Products

(Tablets, Semisolids)